[go: up one dir, main page]

GB202319255D0 - Anti-UNC5C antibodies - Google Patents

Anti-UNC5C antibodies

Info

Publication number
GB202319255D0
GB202319255D0 GBGB2319255.2A GB202319255A GB202319255D0 GB 202319255 D0 GB202319255 D0 GB 202319255D0 GB 202319255 A GB202319255 A GB 202319255A GB 202319255 D0 GB202319255 D0 GB 202319255D0
Authority
GB
United Kingdom
Prior art keywords
unc5c
antibodies
unc5c antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2319255.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alchemab Therapeutics Ltd
Original Assignee
Alchemab Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alchemab Therapeutics Ltd filed Critical Alchemab Therapeutics Ltd
Priority to GBGB2319255.2A priority Critical patent/GB202319255D0/en
Priority to CN202480017275.8A priority patent/CN121419991A/en
Priority to PCT/EP2024/050407 priority patent/WO2024149766A1/en
Priority to JP2025540179A priority patent/JP2026503279A/en
Priority to KR1020257026468A priority patent/KR20250133935A/en
Priority to AU2024207916A priority patent/AU2024207916A1/en
Priority to EP24701314.7A priority patent/EP4649090A1/en
Priority to IL321771A priority patent/IL321771A/en
Priority to PE2025001449A priority patent/PE20252587A1/en
Priority to CR20250274A priority patent/CR20250274A/en
Publication of GB202319255D0 publication Critical patent/GB202319255D0/en
Priority to PCT/IB2024/000719 priority patent/WO2025125898A1/en
Priority to CL2025002020A priority patent/CL2025002020A1/en
Priority to CONC2025/0009241A priority patent/CO2025009241A2/en
Priority to DO2025000164A priority patent/DOP2025000164A/en
Ceased legal-status Critical Current

Links

GBGB2319255.2A 2023-01-09 2023-12-15 Anti-UNC5C antibodies Ceased GB202319255D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB2319255.2A GB202319255D0 (en) 2023-12-15 2023-12-15 Anti-UNC5C antibodies
IL321771A IL321771A (en) 2023-01-09 2024-01-09 Antibodies against unc5c
PE2025001449A PE20252587A1 (en) 2023-01-09 2024-01-09 ANTI-UNC5C ANTIBODIES
JP2025540179A JP2026503279A (en) 2023-01-09 2024-01-09 Anti-UNC5C antibody
KR1020257026468A KR20250133935A (en) 2023-01-09 2024-01-09 anti-UNC5C antibody
AU2024207916A AU2024207916A1 (en) 2023-01-09 2024-01-09 Anti-unc5c antibodies
EP24701314.7A EP4649090A1 (en) 2023-01-09 2024-01-09 Anti-unc5c antibodies
CN202480017275.8A CN121419991A (en) 2023-01-09 2024-01-09 Anti-UNC 5C antibodies
PCT/EP2024/050407 WO2024149766A1 (en) 2023-01-09 2024-01-09 Anti-unc5c antibodies
CR20250274A CR20250274A (en) 2023-01-09 2024-01-09 ANTI-UNC5C antibodies
PCT/IB2024/000719 WO2025125898A1 (en) 2023-12-15 2024-12-13 Anti-unc5c antibodies and uses thereof
CL2025002020A CL2025002020A1 (en) 2023-01-09 2025-07-08 Anti-unc5c antibodies
CONC2025/0009241A CO2025009241A2 (en) 2023-01-09 2025-07-08 Anti-unc5c antibodies
DO2025000164A DOP2025000164A (en) 2023-01-09 2025-07-09 ANTI-UNC5C ANTIBODIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2319255.2A GB202319255D0 (en) 2023-12-15 2023-12-15 Anti-UNC5C antibodies

Publications (1)

Publication Number Publication Date
GB202319255D0 true GB202319255D0 (en) 2024-01-31

Family

ID=89662731

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2319255.2A Ceased GB202319255D0 (en) 2023-01-09 2023-12-15 Anti-UNC5C antibodies

Country Status (1)

Country Link
GB (1) GB202319255D0 (en)

Similar Documents

Publication Publication Date Title
GB202014851D0 (en) SARS-COV-2 antibodies
GB2614651B (en) Antibodies
IL324435A (en) Anti-il1rap antibodies
GB2627309B (en) Antibodies
IL317231A (en) Anti-bcma antibodies
GB202304512D0 (en) Antibodies
GB202217924D0 (en) Antibodies
GB202309981D0 (en) Antibody
GB202204159D0 (en) Antibodies
GB202102227D0 (en) Antibodies
IL325202A (en) Anti-fibril antibodies
IL320725A (en) Anti-beta-catenin antibodies
GB202400120D0 (en) Anti-pgdh antibodies
GB202319255D0 (en) Anti-UNC5C antibodies
GB202318820D0 (en) Antibodies
GB202317371D0 (en) Anti-unc5c antibodies
GB202317192D0 (en) Anti-agr2 antibodies
GB202317189D0 (en) Anti-AGR2 antibodies
GB202317188D0 (en) Anti-AGR2 antibodies
GB202317187D0 (en) Anti-AGR2 antibodies
GB202316016D0 (en) Antibodies
GB202311473D0 (en) Anti-ifnl1/reg3a antibodies
GB202311470D0 (en) Anti-BST2 antibodies
GB202309920D0 (en) Antibodies
GB202308898D0 (en) Anti-fibril antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)